Journal of Dentistry and Oral Epidemiology 33. Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter
40. Jadhao VA, Lokhande N, Habbu SG, Sewane S, Dongare
C, et al. (2018) Onabotulinum toxin-A injections for
S, et al. (2017) Efficacy of botulinum toxin in treating
sleep bruxism: A double-blind, placebo-controlled study.
myofascial pain and occlusal force characteristics of
Neurology. 90(7): e559-e564.
masticatory muscles in bruxism. Indian J Dent Res.
34. Bush FM, Harkins SW, Harrington WG, Price DD.
28(5):493.
(1993) Analysis of gender effects on pain perception and
41. Nixdorf DR, Heo G, Major PW. (2002) Randomized
symptom presentation in temporomandibular pain. Pain.
controlled trial of botulinum toxin A for chronic
53(1): 73-80.
myogenous orofacial pain. Pain. 99(3): 465-473.
35. Rieder CE, Martinoff JT, Wilcox SA. (1983) The
42. Al-Wayli H. (2017) Treatment of chronic pain associated
prevalence of mandibular dysfunction. Part I: Sex and
with nocturnal bruxism with botulinum toxin. A
age distribution of related signs and symptoms. J Prosthet
prospective and randomized clinical study. J Clin Exp
50(1): 81-88.
Dent. 9(1): e112.
36. Abubaker AO, Raslan WF, Sotereanos GC. (1993) Estrogen
and
progesterone
receptors
43. Ernberg M, Hedenberg-Magnusson B, List T, Svensson
in
P. (2011) Efficacy of botulinum toxin type A for
temporomandibular joint discs of symptomatic and
treatment of persistent myofascial TMD pain: a
asymptomatic persons: a preliminary study. J Oral
randomized, controlled, double-blind multicenter study.
Maxillofac Surg. 51(10): 1096-1100.
Pain. 152(9): 1988-1996.
37. Weller JL, Comeau D, Otis JAD. (2018) Myofascial Pain. Semin Neurol. 38(6): 640-643.
44. Graboski CL, Gray DS, Burnham RS. (2005) Botulinum toxin A versus bupivacaine trigger point injections for
38. De Carli BMG, Magro AKD, Souza-Silva BN, de Souza Matos F, De Carli JP, et al. (2016) The effect of laser
the treatment of myofascial pain syndrome: a randomised double blind crossover study. Pain. 118(1-2): 170-175.
andbotulinum toxin in the treatment of myofascial pain
45. von Lindern JJ, Niederhagen B, Bergé S, Appel T. (2003)
and mouth opening: A randomized clinical trial. J
Type A botulinum toxin in the treatment of chronic facial
Photochem Photobiol B. 159: 120-123.
pain associated with masticatory hyperactivity. Journal
39. Guarda-Nardini L, Stecco A, Stecco C, Masiero S, Manfredini D. (2012) Myofascial pain of the jaw muscles:
comparison
of
short-term
effectiveness
ofbotulinum toxin injections and fascial manipulatio technique. CRANIO®. 30(2): 95-102.
of oral and maxillofacial surgery. 61(7): 774-778. 46. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. (2000) Defining the clinically important difference in pain outcome measures. Pain. 88(3): 287-294. 47. Kalichman L, Vulfsons S. (2010) Dry needling in the management of musculoskeletal pain. J Am Board Fam Med. 23(5): 640-64
ACQUIRE PUBLICATIONS Volume 1 Issue 2
www.acquirepublications.org/JDOE
16 16
